Magic Mushroom Compound Tamed One Of Nature’s Most Aggressive Fish

A tiny, aggressive fish that can survive on land and fertilizes its own eggs just became one of science’s most unexpected allies in understanding how psilocybin works on the brain.

Researchers found that exposing the mangrove rivulus to psilocybin through the water caused the animals to calm down and pick fewer fights. Published in Frontiers in Behavioral Neuroscience, the work could give scientists a useful new animal model for studying how psilocybin affects social behavior and adds to growing evidence on the compound’s potential.

Psilocybin is naturally found in more than 200 mushroom species. When consumed, the body converts it into its active form, acting on pathways regulated by serotonin, tied closely to mood, emotion, and behavior. Scientists have been increasingly interested in psilocybin’s potential to treat depression and anxiety, but a major piece of the puzzle has been missing: understanding how it changes social behavior, including aggression, in living animals.

An Unusually Perfect Test Subject for Psilocybin Research

To study psilocybin’s effects on aggression, the team needed a naturally combative fish. They found it in the mangrove rivulus (Kryptolebias marmoratus), a small amphibious species native to brackish coastal waterways. Highly active and frequently aggressive toward one another, these fish were well-suited for the work.

What makes the mangrove rivulus especially valuable is that it is one of only two known fish that can fertilize its own eggs, reproducing without a mate. After multiple generations of self-reproduction in the lab, fish within the same family line end up nearly identical at the genetic level. Researchers used this biology to control for genetic differences, so behavioral changes could be credited to the drug rather than DNA variation. Fish were housed individually at Acadia University in Wolfville, Nova Scotia, with three distinct family lines used.

How the Psilocybin Experiment Was Set Up

Researchers placed a focal fish in a glass tank divided by a mesh barrier, with a size-matched fish on the other side, visible and chemically detectable but physically out of reach.

Researchers filmed 15-minute observation sessions and recorded several behaviors, including movement, aggressive darts toward the barrier, face-to-face and side-by-side displays, and time spent near the divider.

After establishing a behavioral baseline, the focal fish were moved to psilocybin-treated water for 20 minutes. The dose was 3,000 micrograms per liter, identified as the most effective concentration through preliminary trials. About 15 minutes later, each fish was returned to the divided tank and observed again. A control group went through the same process in plain water, with 16 fish per group. All video analysis was conducted without researchers knowing which fish had received the drug.

Psilocybin Reduced Movement and Aggression in Treated Fish

Fish exposed to psilocybin moved significantly less than before treatment, a large effect by statistical standards. Control fish showed no such change, ruling out boredom or fatigue as an explanation.

Psilocybin-treated fish also cut back sharply on aggressive charges across the barrier. Those fast, darting lunges dropped after psilocybin exposure while the control group showed no meaningful change. That reduction was more moderate than the movement finding, but still statistically meaningful.

Other aggressive posturing behaviors declined over time in both groups, likely because the fish were growing familiar with each other, but the clearest drug-linked changes remained reduced movement and fewer aggressive swimming bursts. Researchers also tracked the untreated fish across the barrier, and its behavioral shifts did not differ from those seen when its neighbor had received only plain water, making it less likely the changes were driven by the untreated neighbor rather than the drug.

Getting the Dose Right

Confirming that the fish absorbed a biologically meaningful amount of psilocybin was a key part of the work. Using a lab technique that identifies specific compounds in tissue, the team analyzed whole-body concentrations of psilocybin and its active form in treated fish.

Internal concentrations of the active compound, roughly 7 nanograms per milliliter, were comparable to peak blood levels in humans after a low-to-moderate therapeutic dose. Equating a fish’s waterborne exposure to a human dose is inherently imprecise, but the comparison confirmed the behavioral effects corresponded to a pharmacologically relevant amount, not a trace exposure. Researchers also tried delivering the drug through a psilocybin-laced artificial food worm, but the fish did not absorb it that way.

Why This Small Fish Could Be a Big Deal for Psilocybin Science

Psilocybin research in humans has grown rapidly, with studies suggesting it may help with depression, anxiety, and other conditions where standard medications fall short. But before a drug reaches clinical use, scientists need animal models to understand how it works biologically.

Fish offer real advantages here. They share a surprising amount of genetic and physiological machinery with humans, cost less to maintain than mammals, and the mangrove rivulus’s near-identical genetics let researchers zero in on drug effects without genetic noise.

Individual fish showed considerable variation in how strongly they responded to psilocybin, an interesting finding in itself. It suggests the drug’s effects are not simply a product of genetic makeup.

The paper describes the work as “the first study to demonstrate that psilocybin reduces aggression in any animal model.” If that claim holds up, this self-fertilizing, amphibious fish may prove to be an unlikely but valuable reference point for researchers trying to understand one of the most-discussed compounds in modern medicine.

---